From long-term follow-up Recommendations for clinical practice to plain language summaries for childhood, adolescent, and young adult cancer survivors
Selina R. van den Oever(Princess Máxima Center), Helena J. H. van der Pal, Roderick Skinner(Royal Victoria Infirmary), Carina Schneider, Riccardo Haupt(Istituto Giannina Gaslini), Samira Essiaf(European Society for Paediatric Oncology), Elaine Sugden, Edit Bárdi(Kepler Universitätsklinikum), Jaap den Hartogh(University of Lucerne), Monica Muraca(Istituto Giannina Gaslini), Leontien C.M. Kremer(University Medical Center Utrecht), Ana E. Amariutei, Morven C. Brown(Royal Victoria Infirmary), Emma Potter(Royal Marsden Hospital), Zuzana Tomášiková, Herma Vermeulen(Princess Máxima Center), Hannah Gsell, Gill Levitt(Great Ormond Street Hospital for Children NHS Foundation Trust), Renée L. Mulder(Princess Máxima Center)
Cited by 5
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
|BMC Cancer|2010|755
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
|Circulation|2013|612
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
|The Lancet Oncology|2015|561
Cardioprotective interventions for cancer patients receiving anthracyclines
|Cochrane Database of Systematic Reviews|2011|553